WAVE LIFE SCIENCES LTD. Weighted Average Number of Shares Outstanding, Basic and Diluted
WAVE LIFE SCIENCES LTD. (WVE) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 60.52 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-12
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 60.52M shares, a 23.25% increase year-over-year.
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 57.25M shares, a 17.20% increase year-over-year.
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 50.71M shares, a 32.18% increase year-over-year.
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 49.97M shares, a 41.92% increase year-over-year.
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 51.83M shares, a 32.11% increase from fiscal 2020.
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 39.23M shares, a 15.83% increase from fiscal 2019.
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 33.87M shares, a 16.90% increase from fiscal 2018.
- WAVE LIFE SCIENCES LTD. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 28.97M shares, a 9.27% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 60.52M shares 10-Q · filed 2022-05-12 | 58.88M shares derived: average of 2 quarters · filed 2022-05-12 | 56.16M shares derived: average of 3 quarters · filed 2022-05-12 | 54.61M shares derived: average of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 57.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 53.98M shares derived: average of 2 quarters · filed 2022-03-03 | 52.64M shares derived: average of 3 quarters · filed 2022-03-03 | 51.83M shares 10-K · filed 2022-03-03 |
| 2021-09-30 | 50.71M shares 10-Q · filed 2021-11-10 | 50.34M shares derived: average of 2 quarters · filed 2021-11-10 | 50.02M shares 10-Q · filed 2021-11-10 | 49.66M shares derived: average of 4 quarters · filed 2022-05-12 |
| 2021-06-30 | 49.97M shares 10-Q · filed 2021-08-05 | 49.22M shares 10-Q · filed 2021-08-05 | 49.31M shares derived: average of 3 quarters · filed 2022-05-12 | 46.57M shares derived: average of 4 quarters · filed 2022-05-12 |
| 2021-03-31 | 49.10M shares 10-Q · filed 2022-05-12 | 48.97M shares derived: average of 2 quarters · filed 2022-05-12 | 45.44M shares derived: average of 3 quarters · filed 2022-05-12 | 42.88M shares derived: average of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | 48.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 43.61M shares derived: average of 2 quarters · filed 2022-03-03 | 40.81M shares derived: average of 3 quarters · filed 2022-03-03 | 39.23M shares 10-K · filed 2022-03-03 |
| 2020-09-30 | 38.36M shares 10-Q · filed 2021-11-10 | 36.79M shares derived: average of 2 quarters · filed 2021-11-10 | 36.02M shares 10-Q · filed 2021-11-10 | 35.59M shares derived: average of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | 35.21M shares 10-Q · filed 2021-08-05 | 34.84M shares 10-Q · filed 2021-08-05 | 34.66M shares derived: average of 3 quarters · filed 2021-08-05 | 34.57M shares derived: average of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | 34.46M shares 10-Q · filed 2021-05-13 | 34.39M shares derived: average of 2 quarters · filed 2021-05-13 | 34.35M shares derived: average of 3 quarters · filed 2021-05-13 | 34.33M shares derived: average of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | 34.31M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | 34.29M shares derived: average of 2 quarters · filed 2021-03-04 | 34.28M shares derived: average of 3 quarters · filed 2021-03-04 | 33.87M shares 10-K · filed 2021-03-04 |
| 2019-09-30 | 34.28M shares 10-Q · filed 2020-11-09 | 34.27M shares derived: average of 2 quarters · filed 2020-11-09 | 33.72M shares 10-Q · filed 2020-11-09 | 32.65M shares derived: average of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | 34.26M shares 10-Q · filed 2020-08-10 | 33.43M shares 10-Q · filed 2020-08-10 | 32.11M shares derived: average of 3 quarters · filed 2020-08-10 | 31.41M shares derived: average of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | 32.60M shares 10-Q · filed 2020-05-11 | 31.03M shares derived: average of 2 quarters · filed 2020-05-11 | 30.47M shares derived: average of 3 quarters · filed 2020-05-11 | 30.14M shares derived: average of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | 29.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 29.40M shares derived: average of 2 quarters · filed 2020-03-02 | 29.32M shares derived: average of 3 quarters · filed 2020-03-02 | 28.97M shares 10-K · filed 2020-03-02 |
| 2018-09-30 | 29.33M shares 10-Q · filed 2019-11-05 | 29.24M shares derived: average of 2 quarters · filed 2019-11-05 | 28.80M shares 10-Q · filed 2019-11-05 | 28.55M shares derived: average of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | 29.14M shares 10-Q · filed 2019-08-06 | 28.54M shares 10-Q · filed 2019-08-06 | 28.29M shares derived: average of 3 quarters · filed 2020-03-02 | 28.16M shares derived: average of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | 27.92M shares 10-Q · filed 2019-05-10 | 27.87M shares derived: average of 2 quarters · filed 2020-03-02 | 27.83M shares derived: average of 3 quarters · filed 2020-03-02 | 27.60M shares derived: average of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | 27.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 27.79M shares derived: average of 2 quarters · filed 2020-03-02 | 27.49M shares derived: average of 3 quarters · filed 2020-03-02 | 26.51M shares 10-K · filed 2020-03-02 |
| 2017-09-30 | 27.76M shares 10-Q · filed 2018-11-09 | 27.33M shares derived: average of 2 quarters · filed 2018-11-09 | 26.08M shares 10-Q · filed 2018-11-09 | 25.42M shares derived: average of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | 26.90M shares 10-Q · filed 2018-08-09 | 25.22M shares 10-Q · filed 2018-08-09 | 24.64M shares derived: average of 3 quarters · filed 2019-03-01 | 24.34M shares derived: average of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | 23.53M shares 10-Q · filed 2018-05-09 | 23.51M shares derived: average of 2 quarters · filed 2019-03-01 | 23.49M shares derived: average of 3 quarters · filed 2019-03-01 | 23.29M shares derived: average of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | 23.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | 23.47M shares derived: average of 2 quarters · filed 2019-03-01 | 23.21M shares derived: average of 3 quarters · filed 2019-03-01 | 22.80M shares 10-K · filed 2019-03-01 |
| 2016-09-30 | 23.45M shares 10-Q · filed 2017-11-09 | 23.08M shares derived: average of 2 quarters · filed 2017-11-09 | 22.57M shares 10-Q · filed 2017-11-09 | 20.76M shares derived: average of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | 22.71M shares 10-Q · filed 2017-08-09 | 22.13M shares 10-Q · filed 2017-08-09 | 19.86M shares derived: average of 3 quarters · filed 2018-03-12 | 17.20M shares derived: average of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | 21.55M shares 10-Q · filed 2017-05-10 | 18.44M shares derived: average of 2 quarters · filed 2018-03-12 | 15.36M shares derived: average of 3 quarters · filed 2018-03-12 | 13.83M shares derived: average of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | 15.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | 12.27M shares derived: average of 2 quarters · filed 2018-03-12 | 11.26M shares derived: average of 3 quarters · filed 2018-03-12 | 10.50M shares 10-K · filed 2018-03-12 |
| 2015-09-30 | 9.22M shares 10-Q · filed 2016-11-09 | 9.22M shares derived: average of 2 quarters · filed 2016-11-09 | 8.90M shares 10-Q · filed 2016-11-09 | 7.75M shares derived: average of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | 9.22M shares 10-Q · filed 2016-08-15 | 8.73M shares 10-Q · filed 2016-08-15 | 7.25M shares derived: average of 3 quarters · filed 2017-03-16 | 6.51M shares derived: average of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | 8.27M shares 10-Q · filed 2016-05-16 | 6.27M shares derived: average of 2 quarters · filed 2017-03-16 | 5.60M shares derived: average of 3 quarters · filed 2017-03-16 | |
| 2014-12-31 | 4.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 4.27M shares derived: average of 2 quarters · filed 2017-03-16 | 3.91M shares 10-K · filed 2017-03-16 | |
| 2014-09-30 | 4.26M shares 10-Q · filed 2015-12-17 | 3.79M shares 10-Q · filed 2015-12-17 | ||
| 2013-12-31 | 1.74M shares 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |